Freshpet, Inc. (FRPT) Form 8-K — Nov 4, 2026
Freshpet reported Q3 2026 net sales of $317.8 million, up 10.0% year over year and entirely volume-driven, with Adjusted Gross Margin jumping 400 basis points to 50.0%, its best in over seven years. GAAP net income fell to $29.7 million from $101.7 million, but that decline is explained by a one-time $77.9 million deferred tax benefit in the prior-year quarter. The company raised its FY2026 outlook: net sales growth to 12-13% (from 10-12%) and Adjusted EBITDA to $215-220 million (from $210-220 million), while cutting capex guidance to $125-150 million after unlocking over $100 million of capacity from its existing footprint.
Key figures
- Eps
- 0.58
- Revenue
- 317800000
- Guidance
- FY2026 net sales growth of 12-13% (raised from 10-12%); Adjusted EBITDA of $215-220M (raised from $210-220M); positive Free Cash Flow with capex of $125-150M (lowered from ~$150M). 2027 targets reiterated: >49% Adjusted Gross Margin, 20-22% Adjusted EBITDA margin.
- Net Income
- 29700000
- Total Debt
- 399000000
- Revenue Yoy
- 10.0%
- Cash Position
- 345900000
- Gross margin q3
- 44.5%
- Adjusted ebitda q3
- 64500000
- Free cash flow ytd
- 65300000
- Nine month net sales
- 921100000
- Logistics cost pct q3
- 7.1%
- Prior year net income
- 101700000
- Share repurchases ytd
- 102300000
- Prior year tax benefit
- 77900000
- Nine month sales growth
- 12.8%
- Prior year gross margin
- 39.5%
- Adjusted gross margin q3
- 50.0%
- Adjusted ebitda margin q3
- 20.3%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.